Not all patients with CLL demand therapy. Regardless of all new improvements, the iwCLL continue to recommends watchful observation for people with asymptomatic disease.86 This suggestion is based on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both of those https://nikosy975wfo3.salesmanwiki.com/user